Evidence map›Paper›PMID 25713074›Full record

ArticleThe Journal of biological chemistry2015

Transcriptional activity of erythroid Kruppel-like factor (EKLF/KLF1) modulated by PIAS3 (protein inhibitor of activated STAT3).

Miroslawa Siatecka, Shefali Soni, Antanas Planutis, James J Bieker

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06440603 (Erythroid Krüppel Like Factor), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06440603 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Erythroid Krüppel Like Factor (EKLF) Gene Expression in β-thalassemia Patients

TypeobservationalSponsorRofaida Hassan AhmedRan2024 to 2027Enrolled150Conditionsβ-thalassemiaArmsPCR
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Miroslawa SiateckaFrom the Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, New York 10029 and the Department of Genetics, Institute of Experimental Biology, University of Adam Mickiewicz, 61-614 Poznan, Poland msiatecka@amu.edu.pl.
Shefali SoniFrom the Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, New York 10029 and.
Antanas PlanutisFrom the Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, New York 10029 and.
James J BiekerFrom the Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, New York 10029 and.
Icahn School of Medicine at Mount Sinai · USAdam Mickiewicz University in Poznań · PL

Funding

Function of Putative Determinant in HematopoiesisR01DK046865 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI JAMES J BIEKER · 1993 to 2026
$11.2M
NIDDK NIH HHS R01 DK046865NIDDK NIH HHS R01 DK46865
6 · The paper itself

Abstract

Erythroid Kruppel-like factor (EKLF or KLF1) is a transcription factor crucial for red cell development that is directly involved in regulation of a large number of erythroid genes. EKLF serves mostly as an activator of expression of these genes; however, it can act also as a repressor. Here, we present evidence that EKLF interacts with proteins from the PIAS (protein inhibitor of activated STAT) family that convey repressive activity to EKLF in the absence of sumoylation. Our studies identify PIAS3 as a transcriptional corepressor of EKLF for at least a subset of its target genes during erythropoiesis (e.g. β-globin, α-hemoglobin stabilizing protein). We demonstrate an interaction between EKLF and PIAS proteins confirmed by in vivo coimmunoprecipitation assays with both exogenous and endogenous proteins. We identified an LXXLL signature motif located near the N terminus of PIAS proteins that, although not involved in the EKLF-PIAS3 interaction, is required for the transrepression activity. Knockdown of endogenous PIAS3 accelerates differentiation of both murine erythroleukemia cells, as well as fetal liver cells, whereas an increase in PIAS3 levels inhibits this increase. Using chromatin immunoprecipitation assays, we show that PIAS3 preferentially occupies the β-globin promoter in undifferentiated murine erythroleukemia cells. Together these results demonstrate that an interaction between EKLF and PIAS3 provides a novel mode of regulation of EKLF activity in the absence of sumolylation and furthermore shows an important involvement of PIAS proteins in erythropoiesis.

Indexed as

MutationTranscriptional ActivationAmino Acid MotifsAmino Acid SequenceAnimalsbeta-GlobinsBinding SitesBlotting, WesternCell DifferentiationCell Line, TumorChlorocebus aethiopsCOS CellsHEK293 CellsHumansK562 CellsKruppel-Like Transcription Factorsbeta-Globinserythroid Kruppel-like factorKruppel-Like Transcription FactorsProtein Inhibitors of Activated STATCell DifferentiationErythropoiesisGene RegulationKruppel-like Factor (KLF)LXXLL MotifPIAS3SAP DomainTranscription Coregulator

Identifiers

PMID25713074
PMCPMC4392289
OpenAlexW1990323347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.